T2-“low” asthma: overview and management strategies

AM Fitzpatrick, BE Chipps, F Holguin… - The Journal of Allergy and …, 2020 - Elsevier
Although the term “asthma” has been applied to all patients with airway lability and variable
chest symptoms for centuries, phenotypes of asthma with distinct clinical and molecular …

Severe asthma in children

TW Guilbert, LB Bacharier, AM Fitzpatrick - The Journal of Allergy and …, 2014 - Elsevier
Severe asthma in children is characterized by sustained symptoms despite treatment with
high doses of inhaled corticosteroids or oral corticosteroids. Children with severe asthma …

[HTML][HTML] Severe asthma and quality of life

E Hossny, L Caraballo, T Casale, Y El-Gamal… - World Allergy …, 2017 - Elsevier
Severe asthma has a great impact on the quality of life (QOL) of patients and their families.
The magnitude of this morbidity is affected by several personal factors including age …

Rational oral corticosteroid use in adult severe asthma: a narrative review

LP Chung, JW Upham, PG Bardin, M Hew - Respirology, 2020 - Wiley Online Library
ABSTRACT OCS play an important role in the management of asthma. However, steroid‐
related AE are common and represent a leading cause of morbidity. Limited published …

Development of new therapies for severe asthma

ML Fajt, SE Wenzel - Allergy, Asthma & Immunology …, 2017 - synapse.koreamed.org
Persistent asthma has long been treated with inhaled corticosteroids (CSs), as the mainstay
of therapy. However, their efficacy in patients with more severe disease is limited, which led …

[HTML][HTML] Diagnosis and treatment of severe asthma: a phenotype-based approach

TL Jones, DM Neville, AJ Chauhan - Clinical Medicine, 2018 - Elsevier
Severe asthma is a heterogeneous and often difficult to treat condition that results in a
disproportionate cost to healthcare systems. Appropriate diagnosis and management of …

Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations

R Agarwal, S Dhooria, AN Aggarwal, VN Maturu… - Lung India, 2015 - journals.lww.com
Asthma is defined as a chronic inflammatory disorder of the airways which manifests itself as
recurrent episodes of wheezing, breathlessness, chest tightness and cough. It is …

Efficacy and safety of anti-interleukin-5 therapy in patients with asthma: a systematic review and meta-analysis

FP Wang, T Liu, Z Lan, SY Li, H Mao - PLoS One, 2016 - journals.plos.org
Background Recent trials have assessed the efficacy and safety of novel monoclonal
antibodies such as reslizumab and benralizumab. However, the overall efficacy and safety …

Cost-effectiveness of bronchial thermoplasty, omalizumab, and standard therapy for moderate-to-severe allergic asthma

Z Zafari, M Sadatsafavi, CA Marra, W Chen… - PLoS …, 2016 - journals.plos.org
Background Bronchial thermoplasty (BT) is a recently developed treatment for patients with
moderate-to-severe asthma. A few studies have suggested the clinical efficacy of this …

Guidelines for severe uncontrolled asthma

CC Serrano, CM Moreno, CA Sánchez… - Archivos de …, 2015 - Elsevier
Since the publication, 9 years ago, of the latest SEPAR (Spanish Society of Pulmonology
and Thoracic Surgery) Guidelines on Difficult-to-Control Asthma (DCA), much progress has …